Skip to content

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

QUEST (Quitting Using Executive Function Strategy Training) Research Protocol

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06745154
Enrollment
27
Registered
2024-12-20
Start date
2023-06-26
Completion date
2023-08-30
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking-Related Carcinoma

Brief summary

This clinical trial evaluates the impact of Quitting Using Executive Function Strategy Training (QUEST) on quitting smoking (cessation) in homeless young adult smokers with an acquired brain injury (ABI). Over 70% of youth and young adults experiencing homelessness (YYEH) smoke tobacco. More than half of YYEH who smoke have made at least one attempt to quit smoking but few use evidence-based methods to increase success. In addition, 9 out of 10 of these have an acquired brain injury which may have a negative impact on successful smoking cessation. QUEST may help homeless young adult smokers with an ABI quit smoking.

Detailed description

PRIMARY OBJECTIVES: I. Gather data needed to build QUEST (Quitting Using Executive function Strategy Training), an intervention to help youth and young adults (YYEH) with executive function dysregulation better 1) access evidence-based cessation; 2) adhere to processes of evidence-based treatment; and 3) address stress to prevent relapse. II. Establish the feasibility of collecting acquired brain injury (ABI) status, and impact data sensitive to change over time (clinical and epigenetic), from YYEH tobacco users in community settings. EXPLORATORY OBJECTIVE: I. Determine if 1) executive functioning 2) mild cognitive impairment and 3) epigenetic age & other biomarkers of health risk measures are sensitive to difference by ABI status among YYEH past week combustible tobacco users. OUTLINE: Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.

Interventions

PROCEDUREBiospecimen Collection

Undergo nasal swab collection

PROCEDURECognitive Assessment

Undergo cognitive assessment

OTHERInterview

Ancillary studies

Given nicotine patches, gum, or lozenges

BEHAVIORALSmoking Cessation Intervention

Receive access to the Ohio Tobacco Quit Line

OTHERSurvey Administration

Ancillary studies

Participate in counseling sessions

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* 18-24 years old * Utilizing STAR House ( a drop-in center for youth and young adults experiencing homelessness) services * Use of combustible tobacco product in the last week * Willing to quit smoking in the next 30 days * Acquired Brain Injury (ABI) (15 youth with and 15 without) * CHATS will be used to determine ABI. Ask C, H and A of the CHATS tool. If yes to C OR H and yes to A, that will be considered positive for ABI * Have access to a phone * Willing to use phone for QuitLine (QL) services * Willing to enroll in Ohio Tobacco Quit Line * Willing to share Ohio Tobacco Quit Line portal data with researchers * Willing to provide biospecimens (exhaled air and nasal samples) * Conversational English skills

Design outcomes

Primary

MeasureTime frameDescription
Rate of executive function difficultiesUp to 8 weeksThe number of times participants experience executive function difficulties with adhering to the Quit Line protocol will be recorded via survey questionnaires.
Factors impacting access to evidence-based treatmentUp to 8 weeksAll factors reported by participants via survey questionnaires that impacted their ability to access Quit Line treatment will be recorded.
Contact with QuitlineUp to 8 weeksThe number of contacts each participant had with the Quit Line throughout the study will be recorded via survey questionnaires.
Use of nicotine replacement therapyUp to 8 weeksThe number of times participants made use of nicotine replacement therapies throughout the length of the study will be recorded via survey questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026